Krilogy Financial’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.09M Buy
25,619
+13,591
+113% +$738K 0.03% 368
2026
Q1
$763K Sell
12,028
-34,192
-74% -$2.74M 0.02% 446
2025
Q4
$4.32M Buy
+46,220
New +$4.53M 0.15% 116
2018
Q2
Sell
-69
Closed -$2K 220
2018
Q1
$2K Hold
69
﹤0.01% 679
2017
Q4
$2K Sell
69
-7,480
-99% -$206K ﹤0.01% 678
2017
Q3
$220K Sell
7,549
-131
-2% -$3.62K 0.06% 159
2017
Q2
$213K Buy
7,680
+430
+6% +$11.4K 0.06% 139
2017
Q1
$157K Hold
7,250
0.05% 153
2016
Q4
$157K Hold
7,250
0.05% 153
2016
Q3
$173K Hold
7,250
0.05% 136
2016
Q2
$169K Hold
7,250
0.06% 141
2016
Q1
$136K Buy
+7,250
New +$127K 0.06% 139

Other funds holding BSX

Krilogy Financial's BSX Position: Q2 2026 in Review

Krilogy Financial increased its Boston Scientific (BSX) stake by 113% in Q2 2026, buying an estimated $738K and bringing the position to 25,619 shares worth $1.09M. The position accounts for 0.03% of the portfolio, ranked #368.

Krilogy Financial first reported a position in BSX in Q1 2016 and has held it in 12 quarters since. The position peaked at $4.32M in Q4 2025. 1,470 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • Krilogy Financial held 25,619 shares of Boston Scientific worth $1.09M as of Q2 2026.
  • Krilogy Financial bought 13,591 Boston Scientific shares in Q2 2026, an estimated $738K.
  • Boston Scientific made up 0.03% of Krilogy Financial's portfolio in Q2 2026, its #368 holding.
  • Krilogy Financial first reported a position in Boston Scientific in Q1 2016 and has held it in 12 quarters since.
  • Krilogy Financial's Boston Scientific position peaked at $4.32M in Q4 2025.
  • 1,470 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on Krilogy Financial's 13F filing for Q2 2026, filed 27 Jul 2026.